Badura-Stronka M et al. First case series of Polish patients with cerebrotendinous xanthomatosis and systematic review of cases from the 21st century.Clin Genet. 2021. 1-18. PMID: 34689324.
Brown EE et al. Genetic testing in dyslipidemia: A scientific statement from the National Lipid Association. J Clin Lipidol. 2020;14(4):398-413. doi: 10.1016/j.jacl.2020.04.011. PMID: 32507592.
Mignarri A et al. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014;37(3):421-9. PMID: 24442603.
Mandia D et al. Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults. J Neurol. 2019;266(8):2043-2050. PMID: 31115677.
Koopman BJ et al. Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis.Clin Chim Acta. 1985;152(1-2):115-22. PMID: 4053393.
Lumbreras S et al. Gene supplementation of CYP27A1 in the liver restores bile acid metabolism in a mouse model of cerebrotendinous xanthomatosis. Mol Ther Methods Clin Dev. 2021;22:210-221. PMID: 34485606.
CYP27A1